Rhythm Pharmaceuticals Inc (RYTM)
59.03
-0.33
(-0.56%)
USD |
NASDAQ |
Nov 21, 16:00
61.00
+1.97
(+3.34%)
After-Hours: 05:46
Rhythm Pharmaceuticals Profit Margin (Quarterly): -131.2% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -131.2% |
| June 30, 2024 | -110.9% |
| March 31, 2024 | -544.4% |
| December 31, 2023 | -171.8% |
| September 30, 2023 | -196.2% |
| June 30, 2023 | -243.0% |
| March 31, 2023 | -455.0% |
| Date | Value |
|---|---|
| December 31, 2022 | -483.4% |
| September 30, 2022 | -953.8% |
| June 30, 2022 | -496.4% |
| March 31, 2022 | -3.52K% |
| December 31, 2021 | -2.36K% |
| September 30, 2021 | -3.42K% |
| June 30, 2021 | -12.92K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-12.92K%
Minimum
Jun 2021
-110.9%
Maximum
Jun 2024
-1.86K%
Average
-489.9%
Median
Profit Margin (Quarterly) Benchmarks
| Eli Lilly and Co | 8.48% |
| TG Therapeutics Inc | 4.63% |
| Regeneron Pharmaceuticals Inc | 36.03% |
| Voyager Therapeutics Inc | -36.72% |
| Krystal Biotech Inc | 32.42% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -209.0% |
| Return on Assets | -76.55% |
| Return on Invested Capital | -209.0% |
| Gross Profit Margin (Quarterly) | 88.49% |
| Operating Margin (Quarterly) | -132.0% |
| Return on Net Operating Assets | -705.3% |